Article Details
Retrieved on: 2025-01-19 10:22:10
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses epidemiology's role in understanding respiratory diseases, highlighting AstraZeneca's Fasenra (benralizumab) as a breakthrough treatment for COPD. It addresses chronic lower respiratory diseases, emphasizing biologics over traditional inhaler therapies. Tags connect to the concepts of asthma, antiasthmatic drugs, and emerging treatments in respiratory care.
Article found on: www.financialexpress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here